This is a non-core endpoint: only basic statistics are computed.
Juvenile dermatomyositis
DOID EFO MESH SNOMED Endpoint Browser
M13_JUVDERMATOMYO
juvenile dermatomyositis: Juvenile dermatomyositis (JDM) is the early-onset form of dermatomyositis (DM, see this term), a systemic, autoimmune inflammatory muscle disorder, characterized by proximal muscle weakness, evocative skin lesion, and systemic manifestations.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
M33.0
Hospital discharge: ICD-9
7103A
Cause of death: ICD-10
M33.0
Cause of death: ICD-9
7103A
2 out of 7 registries used, show all original rules.
39
Check minimum number of events None
39
Include endpoints None
39
Remove individuals based on genotype QC
39
M13_JUVDERMATOMYO
Control definitions
Control exclude
M13_SYSTCONNECT
Extra metadata
Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
M33
Name in latin
Dermatomyositis juvenilis
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Juvenile dermatomyositis
based on the number of shared cases.
Broader endpoints:
- Dermatopolymyositis
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 39 | 24 | 15 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
| Mean age at first event (years) | 30.69 | 24.80 | 40.12 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: M13_JUVDERMATOMYO – Juvenile dermatomyositis
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Juvenile dermatomyositis
↥Endpoint not on priority list, no data to show.